Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

PCR Technology Helps Detect Food Pathogens and Spoilage Microorganisms

By Labmedica staff writers
Posted on 28 Apr 2008
Advanced real-time polymerase chain reaction (PCR) technology is increasingly being used in the rapid detection of food pathogens and spoilage microorganisms. More...
The technique allows an exponential amplification of DNA from just a few to more than a billion copies in less than one hour. This enables a significant reduction in the time taken to achieve results in comparison with conventional cultivation techniques.

The increasing use of rapid food safety testing is receiving more and more attention. The major reason for this key trend is that the food industry requires quick and accurate results. Traditional microbiological methods are relatively slow and sometimes inaccurate in comparison to new molecular biologic techniques. Fast and reliable detection systems are therefore the method of choice.

Under its foodproof brand, Biotecon Diagnostics (Potsdam, Germany) has developed real-time PCR detection kits for Enterobacteriaceae plus Enterobacter sakazakii (new), Salmonella, Listeria, Campylobacter, Escherichia coli O157, among others. The range also comprises a unique kit for the screening of beer spoilage organisms as well as genetically modified organism (GMO) testing kits.

To enhance the worldwide launch of its food safety testing systems, Biotecon Diagnostics has formed a strategic marketing alliance with the globally operating Merck (Darmstadt, Germany). Merck sells the foodproof range that has been available in almost all countries of the world since January 1, 2008. More products are expected to be forthcoming later in the year.

Dr. Kornelia Berghof-Jaeger, CEO, Biotecon Diagnostics said, "In this alliance, Merck KGaA will contribute significantly through its expertise in microbiology and its excellent customer relationships. Jointly we are able to fulfill the customer needs by introducing this new technology to the food safety testing labs around the world.”

"For Merck KGaA, this partnership means a consequential advancement in order to underline our leading position in specialty chemicals, especially in analytical reagents and test kits,” commented Wolfgang E. Schmidt, head of microbiology, hygiene, and microscopy at Merck KGaA. "Our philosophy of highest quality demands is perfectly met by the solutions offered by Biotecon Diagnostics.”


Related Links:
Biotecon Diagnostics
Merck

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.